NCT00822393 2020-07-30Clinical Phase III Trial Treosulfan-based Conditioning Versus Reduced-intensity Conditioning (RIC)medac GmbHPhase 3 Completed570 enrolled 1 FDA
NCT00491634 2015-12-02Treosulfan-based Conditioning for Transplantation in AML/MDSSheba Medical CenterPhase 2 Completed24 enrolled
NCT00253513 2012-06-01Treosulfan and Fludarabine in Treating Younger Patients Who Are Undergoing a Donor Stem Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic SyndromeOHSU Knight Cancer InstitutePhase 1/2 Completed60 enrolled 15 charts
NCT01063660 2010-02-05Treosulfan Based Conditioning Acute Myeloid Leukaemia (AML)medac GmbHPhase 2 Completed75 enrolled